Drug | IC50 ± SD1(RF2) | |
---|---|---|
LS180 (μM) | LS180/MX (μΜ) | |
Mitoxantrone | 0.112 ± 0.007 (1.00) | 19.235 ± 2.639 (171.74) |
+ Gedatolisib (0.1 μM) | 0.132 ± 0.007 (1.18) | 17.735 ± 2.489 (158.35) |
+ Gedatolisib (0.2 μM) | 0.109 ± 0.012 (0.97) | 14.824 ± 1.112 (132.36)* |
+ Ko143 (1 μM) | 0.121 ± 0.009 (1.08) | 0.616 ± 0.058 (5.5)* |
Topotecan | 0.098 ± 0.007 (1.00) | 25.683 ± 2.031 (262.07) |
+ Gedatolisib (0.1 μM) | 0.089 ± 0.009 (0.90) | 24.583 ± 1.543 (250.85)* |
+ Gedatolisib (0.2 μM) | 0.087 ± 0.008 (0.89) | 18.632 ± 2.332 (190.12)* |
+ Ko143 (1 μM) | 0.091 ± 0.009 (1.02) | 0.319 ± 0.054 (3.58)* |
SN-38 | 0.111 ± 0.010 (1.00) | 8.299 ± 0.923 (74.76) |
+ Gedatolisib (0.1 μM) | 0.107 ± 0.012 (0.96) | 6.990 ± 0.777 (62.97)* |
+ Gedatolisib (0.2 μM) | 0.106 ± 0.011 (0.95) | 5.676 ± 0.859 (51.62)* |
+ Ko143 (1 μM) | 0.112 ± 0.011 (1.01) | 0.277 ± 0.031 (2.50)* |
Cisplatin | 2.511 ± 0.356 (1.00) | 2.445 ± 0.390 (0.97) |
+ Gedatolisib (0.1 μM) | 2.620 ± 0.321 (1.04) | 2.214 ± 0.342 (0.88) |
+ Gedatolisib (0.2 μM) | 2.582 ± 0.323 (1.03) | 2.564 ± 0.367 (1.02) |
+ Ko143 (1 μM) | 2.391 ± 0.398 (0.95) | 2.523 ± 0.369 (1.01) |